Johnson & Johnson

Serotiny is a cutting-edge brand revolutionizing the field of therapeutic genes. With their high-throughput technology, they invent new genes that encode therapeutic multi-domain proteins, allowing them to tackle complex diseases with precision. Serotiny's innovative approach involves iteratively versioning massive libraries of genes, giving them numerous opportunities to achieve therapeutic goals.

Their next-generation engineering tools, including software, DNA synthesis, and sequencing, help them navigate biological complexity and improve therapeutic properties in various disease contexts. Whether it's optimizing cell killing in hostile tumor microenvironments or successful genome insertion, Serotiny engineers cellular attributes for enhanced therapeutic effects and reduced toxicity. A key focus of Serotiny is the development of Therapeutic Multi-Domain Proteins (tMDPs), which are expressed in the patient's cells, providing new functionalities and unique properties.

They leverage rational design and high-throughput mammalian assays to characterize and optimize tMDPs, while their computational and machine learning capabilities enable data-driven insights. Driven by a passion for curative gene and cell therapies, Serotiny is led by a team of experts and works in collaboration with industry leaders and research institutions. Their recent partnerships, like with Janssen and Tessera, highlight the recognition of Serotiny's expertise in optimizing gene designs and advancing genome engineering technologies.

If you're looking for groundbreaking therapeutic candidates or career opportunities in cell and gene therapy, Serotiny is the brand to watch. Contact them to explore partnership possibilities and join their mission to save lives through innovative genetic solutions